Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (≤ 40 μmol/liter). The hordaland homocysteine study

Journal of Clinical Investigation

Volumn 98, Issue 9, 1996, Pages 2174-2183

  Guttormsen, Anne Berit ^a   Ueland, Per Magne ^a,b   Nesthus, Ingerid ^a   Nygård, Ottar ^a   Schneede, Jörn ^a   Vollset, Stein Emil ^a   Refsum, Helga ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b Department of Clinical Biology   (Norway)

Author keywords

folic acid; genetics; homocysteine; methylenetetrahydrofolate reductase; vitamin treatment

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); COBALAMIN; DNA FRAGMENT; FOLIC ACID; HOMOCYSTEINE; VITAMIN;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENE MUTATION; HOMOCYSTINURIA; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY; VITAMIN INTAKE;

EID: 0029974036     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119024     Document Type: Article

References (42)

1. Boushey, C.J., S.A.A. Beresford, G.S. Omenn, and A.G. Motulsky. 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 274:1049-1057.
2. Perry, I.J., H. Refsum, R.W. Morris, S.B. Ebrahim, P.M. Ueland, and A.G. Shaper. 1995. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 346:1395-1398.
3. Finkelstein, J.D. 1990. Methionine metabolism in mammals. J. Nutr. Biochem. 1:228-237.
4. Ueland, P.M., H. Refsum, S.P. Stabler, M.R. Malinow, A. Andersson, and R.H. Allen. 1993. Total homocysteine in plasma or serum. Methods and clinical applications. Clin. Chem. 39:1764-1779.
5. Mudd, S.H., H.L. Levy, and F. Skovby. 1995. Disorder of transsulfuration. In The metabolic basis of inherited disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valles, editors. McGraw-Hill Inc., New York. 1279-1327.
6. Kang, S-S., P.W.K. Wong, and M.R. Malinow. 1992. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu. Rev. Nutr. 12:279-298.
7. Allen, R.H., S.P. Stabler, D.G. Savage, and J. Lindenbaum. 1994. Metabolic abnormalities in cobalamin (vitamin-B12) and folate deficiency. FASEB J. 7:1344-1353.
8. Frosst, P., H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, R.G. Matthews, G.H.J. Boers, M. den Heijer, L.A.J. Kluijtmans, L.P. van den Heuvel et al. 1995. Identification of a candidate genetic risk factor for vascular disease: A common mutation at the methylenetetrahydrofolate reductase locus. Nat. Genet. 10:111-113.
9. Engbersen, A.M.T., D.G. Franken, G.H.J. Boers, E.M.B. Stevens, F.J.M. Trijbels, and H.J. Blom. 1995. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am. J. Hum. Genet. 56:142-150.
10. Kang, S.-S., J. Zhou, P.W.K. Wong, J. Kowalisyn, and G. Strokosch. 1988. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase. Am. J. Hum. Genet. 43:414-421.
11. van der Put, N.M.J., R.P.M. Steegers-Theunissen, P. Frosst, F.J.M. Trijbels, T.K.A.B. Eskes, L.P. van den Heuvel, E.C.M. Mariman, M. den Heijer, R. Rozen, and H.J. Blom. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 346:1070-1071.
12. Whitehead, A.S., P. Gallagher, J.L. Mills, P.N. Kirke, H. Burke, A.M. Molloy, D.G. Weir, D.C. Shields, and J.M. Scott. 1995. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q. J. Med. 88:763-766.
13. Kang, S-S., E.L. Passen, N. Ruggie, P.W.K. Wong, and H. Sora. 1993. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 88:1463-1469.
14. Nygård, O., S.E. Vollset, H. Refsum, I. Stensvold, A. Tverdal, J.E. Nordrehaug, P.M. Ueland, and G. Kvåle. 1995. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA. 274:1526-1533.
15. Guttormsen, A.B., J. Schneede, P.M. Ueland, and H. Refsum. 1996. Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency. Am. J. Clin. Nutr. 63:194-202.
16. Hjertén, S. 1985. High-performance electrophoresis. Elimination of electroendosmosis and solute adsorption. J. Chromatogr. 347:191-198.
17. Skeidsvoll, J., and P.M. Ueland. 1995. Analysis of double-stranded DNA by capillary electrophoresis with laser-induced fluorescence detection using the monomeric dye SYBR green I. Anal. Biochem. 231:359-365.
18. Fiskerstrand, T., H. Refsum, G. Kvalheim, and P.M. Ueland. 1993. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin. Chem. 39:263-271.
19. Refsum, H., P.M. Ueland, and A.M. Svardal. 1989. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin. Chem. 35:1921-1927.
20. Schneede, J., and P.M. Ueland. 1995. Application of capillary electrophoresis with laser-induced fluorescence detection for routine determination of methylmalonic acid in human serum. Anal. Chem. 67:812-819.
21. Bland, J.M., and D.G. Altman. 1994. Regression towards the mean. Br. Med. J. 308:1499.
22. Motulsky, A.G. 1996. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am. J. Hum. Genet. 58:17-20.
23. Selhub, J., P.F. Jacques, P.W.F. Wilson, D. Rush, and I.H. Rosenberg. 1993. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 270:2693-2698.
24. Ubbink, J.B., W.J.H. Vermaak, A. van der Merwe, and P.J. Becker. 1993. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am. J. Clin. Nutr. 57:47-53.
25. Miller, J.W., M.R. Nadeau, D. Smith, and J. Selhub. 1994. Vitamin B-6 deficiency vs folate deficiency - comparison of responses to methionine loading in rats. Am. J. Clin. Nutr. 59:1033-1039.
26. Miller, J.W., J.D. Ribayamercado, R.M. Russell, D.C. Shepard, F.D. Morrow, E.F. Cochary, J.A. Sadowski, S.N. Gershoff, and J. Selhub. 1992. Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations. Am. J. Clin. Nutr. 55:1154-1160.
27. Ubbink, J.B., W.J.H. Vermaak, A. van der Merwe, P.J. Becker, R. Delport, and H.C. Potgieter. 1994. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutr. 124:1927-1933.
28. Franken, D.G., G.H.J. Boers, H.J. Blom, F.J.M. Trijbels, and P.W.C. Kloppenborg. 1994. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler. Thromb. 14:465-470.
29. Jacques, P.F., A.G. Bostom, R.R. Williams, R.C. Ellison, J.H. Eckfeldt, I.H. Rosenberg, J. Selhub, and R. Rozen. 1996. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 93:7-9.
30. Harmon, D.L., J.V. Woodside, J.W.G. Yarnell, D. McMaster, I.S. Young, E.E. McCrum, K.F. Gey, and A.S. Whitehead. 1996. The common "thermolabile" variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinemia. Q. J. Med. 89:571-577.
31. Kluijtmans, L.A.J., L.P.W.J. VandenHeuvel, G.H.J. Boers, P. Frosst, B.A. VanOost, M. den Heijer, E.M.B. Stevens, J.M.F. Trijbels, R. Rozen, and H.J. Blom. 1996. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am. J. Hum. Genet. 58:35-41.
32. Brattström, L.E., B.L. Hultberg, and J.E. Hardebo. 1985. Folic acid responsive postmenopausal homocysteinemia. Metab. Clin. Exp. 34:1073-1077.
33. Brattström, L.E., B. Israelsson, J.-O. Jeppsson, and B.L. Hultberg. 1988. Folic acid - an innocuous means to reduce plasma homocysteine. Scand. J. Clin. Lab. Invest. 48:215-221.
34. Brattström, L., B. Israelsson, B. Norrving, D. Bergqvist, J. Thörne, B. Hultberg, and A. Hamfelt. 1990. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease - effects of pyridoxine and folic acid treatment. Atherosclerosis. 81:51-60.
35. Naurath, H.J., E. Joosten, R. Riezler, S.P. Stabler, R.H. Allen, and J. Lindenbaum. 1995. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentration. Lancet. 346:85-89.
36. Ubbink, J.B., P.J. Becker, W.J.H. Vermaak, and R. Delport. 1995. Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clin. Chem. 41:1033-1037.
37. Rasmussen, K., J. Møller, M. Lyngbak, A.-M. Holm Pedersen, and L. Dybkjaer. 1996. Age and gender specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin. Chem. 42:630-636.
38. Jacob, R.A., M.M. Wu, S.M. Henning, and M.E. Swendseid. 1994. Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction. J. Nutr. 124:1072-1080.
39. O'Keefe, C.A., L.B. Bailey, E.A. Thomas, S.A. Hofler, B.A. Davis, J.J. Cerda, and J.F. Gregory. 1995. Controlled dietary folate affects folate status in nonpregnant women. J. Nutr. 125:2717-2725.
40. Horns, E.K., P. Kanotsky, G. Shakarji, and E. Cotlove. 1970. Biological and analytical components of variation in long-term studies of serum constituents in normal subjects: II. Estimating biological components of variation. Clin. Chem. 16:1022-1027.
41. Williams, G.Z., D.S. Young, M.R. Stein, and E. Cotlove. 1970. Biological and analytical components of variation in long-term studies of serum constituents in normal subjects. I. Objective, subject selection, laboratory procedures, and estimation of analytic deviation. Clin. Chem. 16:1016-1021.
42. Gardner, M.J., and J.A. Heady. 1973. Some effects of within-person variability in epidemiological studies. J. Chron. Dis. 26:781-795.